Ethos Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$991K Buy
8,144
+16
+0.2% +$1.85K 0.07% 198
2025
Q4
$863K Buy
8,128
+1,664
+26% +$156K 0.06% 212
2025
Q3
$548K Sell
6,464
-177
-3% -$14.6K 0.04% 255
2025
Q2
$531K Sell
6,641
-482
-7% -$38.3K 0.05% 250
2025
Q1
$714K Hold
7,123
0.07% 184
2024
Q4
$714K Buy
7,123
+864
+14% +$89.1K 0.09% 126
2024
Q3
$716K Sell
6,259
-132
-2% -$15.7K 0.12% 100
2024
Q2
$796K Sell
6,391
-320
-5% -$41.2K 0.14% 93
2024
Q1
$891K Sell
6,711
-9
-0.1% -$1.11K 0.17% 85
2023
Q4
$738K Buy
6,720
+1,046
+18% +$109K 0.16% 99
2023
Q3
$588K Buy
5,674
+1,746
+44% +$188K 0.15% 84
2023
Q2
$421K Hold
3,928
0.14% 78
2023
Q1
$421K Sell
3,928
-95
-2% -$10.3K 0.13% 94
2022
Q4
$449K Buy
+4,023
New +$411K 0.15% 83

Other funds holding MRK

Ethos Financial Group's MRK Position: Q1 2026 in Review

Ethos Financial Group increased its Merck (MRK) stake by 0.2% in Q1 2026, buying an estimated $1.85K and bringing the position to 8,144 shares worth $991K. The position accounts for 0.07% of the portfolio, ranked #198.

Ethos Financial Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ethos Financial Group held 8,144 shares of Merck worth $991K as of Q1 2026.
  • Ethos Financial Group bought 16 Merck shares in Q1 2026, an estimated $1.85K.
  • Merck made up 0.07% of Ethos Financial Group's portfolio in Q1 2026, its #198 holding.
  • Ethos Financial Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ethos Financial Group's 13F filing for Q1 2026, filed 5 May 2026.